http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018524051-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2448 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0014 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2466 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2445 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-24 |
| filingDate | 2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2018524051-A |
| titleOfInvention | Heart valve repair device configured for transcutaneous delivery |
| abstract | Disclosed herein is a device that improves mitral leaflet joints to reduce or eliminate mitral regurgitation. The device may be used to perform mitral valvuloplasty or serve as a docking station for a transcatheter prosthetic heart valve. Various embodiments of the device are configured for transcutaneous delivery and, in some cases, for transfusion delivery. Also disclosed are delivery systems useful for delivering devices to the mitral valve, including catheters, balloons, and / or mechanical expansion systems. The device itself includes at least one tissue penetrating member. The method of delivery includes partially implanting the device into the mitral annulus via at least one tissue penetrating member. The tissue penetrating member may be implanted in the tissue in a simultaneous or near simultaneous manner. Upon implantation, the device adjusts the mitral valve diameter using various expansion and / or contraction mechanisms. The adjustment may continue until the leaflets are fully joined and mitral regurgitation problems are reduced or eliminated. |
| priorityDate | 2015-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.